Carmen Jacome

Carmen Jacome has extensive work experience in program and project management in the biopharmaceutical industry. Carmen is currently the Vice President of Program Management at Ascidian Therapeutics since 2023. Prior to that, they served as the Senior Director of Program Management at Astria Therapeutics, Inc. from 2021 to 2022 and at Flexion Therapeutics from 2017 to 2020. Carmen also held the position of Director of Project Management at Cempra Pharmaceuticals in 2016 and at Oxurion NV (previously Thrombogenics NV) from 2013 to 2015.

Carmen Jacome has a Master of Business Administration (MBA) degree in International Business from the Darla Moore School of Business. Additionally, they have obtained a Graduate Certificate in Program Management from Stanford University. The specific years of their education are not provided.